VELAN CAPITAL INVESTMENT MANAGEMENT LP Holdings

VELAN CAPITAL INVESTMENT MANAGEMENT LP is an investment fund managing more than 100.82M US dollars. The largest holdings include SPDR EURO STOXX 50 ETF, Lantheus Holdings and Immunocore Holdings. In Q3 2022 the fund bought assets of total value of 16.05M US dollars and sold assets of total value of 4.98M US dollars.

$100.81M

portfolio value

+4.44%

quarter

VELAN CAPITAL INVESTMENT MANAGEMENT LP portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q1 2022	26782000	17722000
Q2 2022	11009000	13423000
Q3 2022	16054000	4977000

VELAN CAPITAL INVESTMENT MANAGEMENT LP 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
SPDR EURO STOXX 50 ETF Portfolio share: 15.26% Portfolio value: 15.38M Avg. open price: N/A Current price: $39.75 P/L: N/A N/A Q3 2022	put	15.26%	15.38M	N/A	$39.75	N/A	N/A Q3 2022
Drug Manufacturers—Specialty & Generic Lantheus Holdings, Inc. Portfolio share: 13.95% Portfolio value: 14.06M Avg. open price: N/A Current price: $56.01 P/L: N/A Sold -25.56% shares Q3 2022	share	13.95%	14.06M	N/A	$56.01	N/A	Sold -25.56% shares Q3 2022
Biotechnology Immunocore Holdings plc Portfolio share: 13.66% Portfolio value: 13.77M Avg. open price: N/A Current price: $58.07 P/L: N/A N/A Q4 2021	share	13.66%	13.77M	N/A	$58.07	N/A	N/A Q4 2021
Biotechnology ADMA Biologics, Inc. Portfolio share: 12.70% Portfolio value: 12.80M Avg. open price: $1.51 Current price: $3.25 P/L: +115.00% Sold -13.24% shares Q3 2022	share	12.70%	12.80M	$1.51	$3.25	+115.00%	Sold -13.24% shares Q3 2022
Drug Manufacturers—Specialty & Generic OptiNose, Inc. Portfolio share: 7.90% Portfolio value: 7.96M Avg. open price: $3.66 Current price: $1.73 P/L: -52.73% Bought +8.83% shares Q3 2022	share	7.90%	7.96M	$3.66	$1.73	-52.73%	Bought +8.83% shares Q3 2022
Medical Devices TELA Bio, Inc. Portfolio share: 6.31% Portfolio value: 6.35M Avg. open price: $9.26 Current price: $8.6 P/L: -7.16% Bought +49.75% shares Q3 2022	share	6.31%	6.35M	$9.26	$8.6	-7.16%	Bought +49.75% shares Q3 2022
Medical Care Facilities Healthcare Services Group, Inc. Portfolio share: 4.80% Portfolio value: 4.83M Avg. open price: $17.62 Current price: $13.66 P/L: -22.47% Bought +131.21% shares Q3 2022	share	4.80%	4.83M	$17.62	$13.66	-22.47%	Bought +131.21% shares Q3 2022
Drug Manufacturers—General Horizon Therapeutics Public Limited Company Portfolio share: 4.23% Portfolio value: 4.26M Avg. open price: $79.76 Current price: $98.48 P/L: +23.47% Bought +2219.82% shares Q3 2022	share	4.23%	4.26M	$79.76	$98.48	+23.47%	Bought +2219.82% shares Q3 2022
Medical Devices Quipt Home Medical Corp. Portfolio share: 3.31% Portfolio value: 3.33M Avg. open price: $4.62 Current price: $4.33 P/L: -6.28% Bought +164.81% shares Q3 2022	share	3.31%	3.33M	$4.62	$4.33	-6.28%	Bought +164.81% shares Q3 2022
Biotechnology BioCryst Pharmaceuticals, Inc. Portfolio share: 2.81% Portfolio value: 2.83M Avg. open price: N/A Current price: $11.58 P/L: N/A N/A Q2 2022	share	2.81%	2.83M	N/A	$11.58	N/A	N/A Q2 2022
Medical Care Facilities The Oncology Institute, Inc. Portfolio share: 2.52% Portfolio value: 2.54M Avg. open price: N/A Current price: $1.33 P/L: N/A Sold -8.53% shares Q3 2022	share	2.52%	2.54M	N/A	$1.33	N/A	Sold -8.53% shares Q3 2022
Biotechnology Jasper Therapeutics, Inc. Portfolio share: 2.22% Portfolio value: 2.24M Avg. open price: N/A Current price: $0.58 P/L: N/A N/A Q4 2021	share	2.22%	2.24M	N/A	$0.58	N/A	N/A Q4 2021
Biotechnology Zymeworks Inc. Portfolio share: 1.43% Portfolio value: 1.44M Avg. open price: N/A Current price: $7.62 P/L: N/A N/A Q3 2022	share	1.43%	1.44M	N/A	$7.62	N/A	N/A Q3 2022
Medical Care Facilities Sonida Senior Living, Inc. Portfolio share: 1.33% Portfolio value: 1.34M Avg. open price: N/A Current price: $16.26 P/L: N/A N/A Q4 2021	share	1.33%	1.34M	N/A	$16.26	N/A	N/A Q4 2021
Drug Manufacturers—Specialty & Generic Alimera Sciences, Inc. Portfolio share: 1.15% Portfolio value: 1.15M Avg. open price: $5.47 Current price: $3.58 P/L: -34.55% Bought +21.71% shares Q3 2022	share	1.15%	1.15M	$5.47	$3.58	-34.55%	Bought +21.71% shares Q3 2022
Biotechnology Rezolute, Inc. Portfolio share: 1.09% Portfolio value: 1.09M Avg. open price: $3.38 Current price: $1.71 P/L: -49.41% Bought +33.33% shares Q2 2022	share	1.09%	1.09M	$3.38	$1.71	-49.41%	Bought +33.33% shares Q2 2022
Biotechnology BELLUS Health Inc. Portfolio share: 1.05% Portfolio value: 1.05M Avg. open price: N/A Current price: $10.02 P/L: N/A N/A Q3 2022	share	1.05%	1.05M	N/A	$10.02	N/A	N/A Q3 2022
Medical Devices Conformis, Inc. Portfolio share: 0.98% Portfolio value: 986K Avg. open price: $0.69 Current price: $3.43 P/L: +394.65% Bought +11.02% shares Q2 2022	share	0.98%	986K	$0.69	$3.43	+394.65%	Bought +11.02% shares Q2 2022
Biotechnology Xenon Pharmaceuticals Inc. Portfolio share: 0.72% Portfolio value: 722K Avg. open price: N/A Current price: $38.83 P/L: N/A N/A Q2 2022	share	0.72%	722K	N/A	$38.83	N/A	N/A Q2 2022
Drug Manufacturers—Specialty & Generic Collegium Pharmaceutical, Inc. Portfolio share: 0.63% Portfolio value: 640K Avg. open price: N/A Current price: $22.73 P/L: N/A N/A Q3 2022	share	0.63%	640K	N/A	$22.73	N/A	N/A Q3 2022
Diagnostics & Research LumiraDx Limited Portfolio share: 0.58% Portfolio value: 583K Avg. open price: N/A Current price: $1.23 P/L: N/A N/A Q3 2022	share	0.58%	583K	N/A	$1.23	N/A	N/A Q3 2022
Drug Manufacturers—Specialty & Generic Assertio Holdings, Inc. Portfolio share: 0.53% Portfolio value: 533K Avg. open price: N/A Current price: $3.29 P/L: N/A N/A Q3 2022	share	0.53%	533K	N/A	$3.29	N/A	N/A Q3 2022
NYXOAH S A Portfolio share: 0.49% Portfolio value: 498K Avg. open price: N/A Current price: N/A P/L: N/A Sold -13.16% shares Q3 2022	share	0.49%	498K	N/A	N/A	N/A	Sold -13.16% shares Q3 2022
Medical Devices Glaukos Corporation Portfolio share: 0.36% Portfolio value: 367K Avg. open price: N/A Current price: $45.88 P/L: N/A N/A Q3 2022	share	0.36%	367K	N/A	$45.88	N/A	N/A Q3 2022
SOMALOGIC INC Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: N/A P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	N/A	N/A	Sold -100.00% shares Q3 2022
Drug Manufacturers—Specialty & Generic Radius Health, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $7.23 Current price: $10.08 P/L: +39.44% Sold -100.00% shares Q3 2022	call	0.00%	0	$7.23	$10.08	+39.44%	Sold -100.00% shares Q3 2022
Biotechnology Caribou Biosciences, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $9.14 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$9.14	N/A	Sold -100.00% shares Q3 2022
Drug Manufacturers—Specialty & Generic Radius Health, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $7.23 Current price: $10.08 P/L: +39.44% Sold -100.00% shares Q3 2022	share	0.00%	0	$7.23	$10.08	+39.44%	Sold -100.00% shares Q3 2022
GRAF ACQUISITION CORP IV Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: N/A P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	N/A	N/A	Sold -100.00% shares Q3 2022
SPDR S&P Biotech ETF Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $82.88 P/L: N/A Sold -100.00% shares Q3 2022	call	0.00%	0	N/A	$82.88	N/A	Sold -100.00% shares Q3 2022
Health Information Services Science 37 Holdings, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $0.61 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$0.61	N/A	Sold -100.00% shares Q3 2022

Showing TOP 31 VELAN CAPITAL INVESTMENT MANAGEMENT LP's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of VELAN CAPITAL INVESTMENT MANAGEMENT LP?

The biggest position of the VELAN CAPITAL INVESTMENT MANAGEMENT LP is SPDR EURO STOXX 50 ETF (FEZ) with 15.26% portfolio share worth of 15.38M US dollars.

Top 5 VELAN CAPITAL INVESTMENT MANAGEMENT LP's holdings represent 63.47% of the portfolio:

SPDR EURO STOXX 50 ETF (FEZ) – 15.26%
Lantheus Holdings, Inc. (LNTH) – 13.95%
Immunocore Holdings plc (IMCR) – 13.66%
ADMA Biologics, Inc. (ADMA) – 12.7%
OptiNose, Inc. (OPTN) – 7.9%

Who is the portfolio manager of VELAN CAPITAL INVESTMENT MANAGEMENT LP?

The portfolio manager of the VELAN CAPITAL INVESTMENT MANAGEMENT LP is .

What is the total asset value of the VELAN CAPITAL INVESTMENT MANAGEMENT LP portfolio?

VELAN CAPITAL INVESTMENT MANAGEMENT LP total asset value (portfolio value) is 100.82M US dollars.

Who is ?

is the portfolio manager of the VELAN CAPITAL INVESTMENT MANAGEMENT LP.

What is (VELAN CAPITAL INVESTMENT MANAGEMENT LP) fund performance?

VELAN CAPITAL INVESTMENT MANAGEMENT LP's quarterly performance is +4.44%, annualy 0.00%.

What is the VELAN CAPITAL INVESTMENT MANAGEMENT LP CIK?

VELAN CAPITAL INVESTMENT MANAGEMENT LP's Central Index Key is 0001848809 .